vivo
tissu
chamber
model
develop
enabl
studi
local
cytokin
product
cellular
event
inflammatori
immun
reaction
pig
tissu
chamber
made
sialist
rubber
tube
surgic
implant
subcutan
tissu
sampl
tissu
chamber
fluid
tcf
inflammatori
cell
collect
aspir
syring
evalu
model
local
cytokin
product
two
cytokin
induc
polyribinosinicpolyribocytidyl
acid
poli
c
fix
aujeszki
diseas
viru
infect
cell
inject
tissu
chamber
sampl
tcf
collect
h
post
inject
poli
c
inject
induc
local
product
interferona
ifncx
well
tumor
necrosi
factor
tnf
tcf
kinet
differ
product
cytokin
note
poli
c
also
induc
increas
cell
number
tcf
mainiy
due
increas
neutrophil
number
inject
induc
local
ifna
product
tcf
long
pig
serolog
neg
adv
immunofluoresc
situ
hybrid
techniqu
could
appli
character
tcf
cell
moreov
cell
recov
tissu
chamber
viabl
could
use
function
vitro
test
taken
togeth
tissu
chamber
model
could
prove
use
correspond
author
immunolog
v
bmc
box
uppsala
sweden
tel
fax
elsevi
scienc
bv
right
reserv
pii
e
wattrang
et
al
veterinari
immunolog
immunopatholog
vivo
studi
inflammatoryimmun
respons
cytokin
product
pig
elsevi
scienc
bv
cytokin
crucial
initi
immun
reaction
well
modul
ensu
immun
respons
avail
reagent
detect
cytokin
increas
consider
recent
year
also
domest
speci
pig
murtaugh
myer
murthaugh
porcin
cytokin
regul
howev
sole
interest
field
veterinari
medicin
sinc
swine
increasingli
use
model
human
diseas
misfeldt
grimm
also
potenti
donor
xenotransplant
sach
product
sever
porcin
cytokin
induc
studi
vitro
la
bonnardihr
et
al
murtaugh
result
obtain
condit
necessarili
reflect
vivo
situat
thu
reliabl
practic
model
vivo
studi
porcin
cytokin
would
benefici
better
understand
initi
regul
immun
respons
sever
approach
studi
local
immun
respons
vivo
cannul
lymphat
vessel
miyasaka
trnka
vacuum
blister
wisselink
et
al
variou
type
tissu
chamber
higgin
et
al
vaudaux
et
al
dawson
et
al
made
tissu
chamber
model
perfor
chamber
creat
artifici
fluid
fill
compart
eg
subcutan
tissu
clark
varieti
chamber
use
sever
speci
model
develop
pharmacolog
studi
type
also
use
purpos
instanc
tissu
chamber
use
monitor
cellular
cytokin
respons
infect
inflammatori
stimuli
mice
dawson
et
al
guineapig
vaudaux
et
al
hors
higgin
et
al
present
studi
partial
perfor
chamber
made
sialist
rubber
tube
implant
subcutan
pig
particular
design
tissu
chamber
adopt
bovin
model
use
pharmacokinet
studi
antibacteri
bengtsson
et
al
bengtsson
similar
chamber
also
use
rabbit
dog
rat
sheep
calnan
et
al
chisholm
et
al
pierci
fluid
chamber
consid
product
young
capillari
network
granul
tissu
invad
chamber
commun
gener
interstiti
fluid
compart
diffus
rate
chamber
fluid
rapid
small
molecul
sodium
slower
larger
molecul
albumin
bergan
evalu
present
porcin
model
two
type
cytokin
induc
use
solubl
particul
induc
ie
polyribinosinicpolyribocytidyl
acid
poli
c
fix
aujeszki
diseas
viru
adv
infect
cell
earlier
use
vivo
interferon
ifn
induct
pig
vengri
mar
loewen
derbyshir
artursson
et
al
addit
monitor
induc
shortterm
cytokin
cellular
respons
tissu
chamber
fluid
also
evalu
function
endur
nine
spfbarrow
includ
studi
approv
ethic
committe
anim
experi
uppsala
sweden
anim
hous
spfcondit
two
pig
per
pen
nation
veterinari
institut
uppsala
sweden
experi
divid
two
set
four
pig
first
five
pig
second
set
anim
week
age
oper
studi
end
month
age
tissu
chamber
use
made
sialist
rubber
tube
ab
labassco
partil
sweden
seal
end
sialist
rubber
plug
ab
labassco
two
size
chamber
use
smaller
mm
length
inner
diamet
mm
larger
mm
long
inner
diamet
mm
hole
mm
diamet
punch
tube
end
chamber
leav
midsect
mm
length
smaller
size
mm
larger
size
tissu
chamber
unperfor
pig
anaesthet
azaperon
mg
kg
bodi
weight
im
stresnil
jensen
pharmaceut
beers
belgium
combin
methomid
mg
kg
bodi
weight
ip
hypnodil
jensen
pharmaceut
oper
site
shave
wash
accord
routin
surgic
procedur
tissu
chamber
insert
skin
incis
subcutan
tunnel
creat
blunt
dissect
use
pair
pean
forcep
skin
wound
stitch
interrupt
sutur
use
polyamid
c
usp
suturamid
ethicon
nordterstedt
germani
sutur
remov
day
post
surgeri
first
set
pig
two
chamber
implant
per
pig
two
pig
one
chamber
later
neck
one
flank
region
two
pig
one
flank
second
set
pig
four
chamber
implant
pig
one
side
neck
flank
tissu
chamber
use
neck
region
smaller
size
first
set
pig
second
set
tissu
chamber
use
larger
size
sampl
bacteriolog
enrich
cultiv
aerob
well
anaerob
condit
isol
bacteria
identifi
accord
routin
procedur
divis
bacteriolog
nation
veterinari
institut
uppsala
sweden
autopsi
month
post
surgeri
sampl
tissu
chamber
tissu
surround
well
lymph
node
collect
sampl
fix
formalin
section
hematoxylineosin
stain
pig
immobil
snout
restrain
sampl
tcf
collect
punctur
skin
midsect
chamber
wall
mm
diamet
needl
aspir
steril
syring
tcf
subsequ
transfer
steril
blood
collect
tube
mg
edta
k
addit
bd
vacutain
meylan
cedex
franc
total
number
nucleat
cell
per
ml
tcf
determin
sampl
stain
tiirk
solut
use
fuchsrosenth
hemacytomet
kebo
ab
stockholm
sweden
sampl
centrifug
cell
free
supernat
collect
store
analysi
ident
function
capac
cell
recov
tcf
examin
describ
otherwis
indic
one
tissu
chamber
inject
cytokin
induc
anoth
chamber
inject
equal
amount
steril
pyrogen
free
physiolog
salin
solut
naci
baxter
medic
ab
kista
sweden
treat
anim
inject
made
collect
first
tcf
sampl
whereaft
tcf
sampl
collect
h
postinject
otherwis
indic
text
experi
untreat
anim
includ
sampl
tcf
collect
one
chamber
time
point
treat
anim
poli
c
doubl
strand
steril
pharmacia
uppsala
sweden
dissolv
nacl
accord
manufactur
instruct
mg
poli
c
volum
ml
inject
per
chamber
adv
infect
porcin
kidney
flow
laboratori
irvin
scotland
uk
cell
prepar
accord
artursson
et
al
slight
modif
brief
confluent
monolay
cell
trypsin
transfer
silicon
tube
x
ml
complet
dulbecco
modif
eagl
medium
dmem
fc
thereaft
infect
adv
id
ml
strain
bartha
h
cell
subsequ
wash
pb
fix
glutaraldehyd
advinfect
cell
inactiv
treatment
j
uvirradi
per
cm
non
infect
cell
prepar
parallel
cell
prepar
verifi
free
infecti
adv
particl
accord
enzym
link
limulu
amaebocyt
lysat
test
coatest
endotoxin
chromogenix
ab
miilndal
sweden
cell
prepar
also
free
endotoxin
cell
suspend
approxim
ml
nacl
x
cell
uninfect
cell
inject
tissu
chamber
tcf
well
serum
sampl
analyz
content
ifn
ifni
tnf
respect
level
ifna
determin
dissociationenhanc
lanthanid
fluoroimmunoassay
delfia
porcin
ifn
w
describ
artursson
et
al
ifni
determin
similar
delfia
base
two
monoclon
antibodi
mab
vandenbroeck
et
al
kindli
provid
b
charley
c
la
bonnadier
laboratoir
de
virologi
et
immunologi
moleculair
inra
jouy
en
josa
franc
tracer
antibodi
label
eu
lanthanid
chelat
eu
ig
sensit
immunoassay
pg
ifn
linear
rang
detect
continu
pg
accord
standard
recombin
porcin
ifni
cibageigi
ltd
basel
switzerland
tnf
activ
measur
bioassay
cell
describ
bertoni
et
al
slight
modif
standard
human
recombin
tnfa
genzym
diagnost
cambridg
usa
includ
everi
test
plate
u
tnf
defin
dilut
destroy
cell
determin
stain
crystal
violet
cell
count
carri
hematoxylineosin
stain
cytospin
shandon
southern
product
ltd
astmoor
runcom
uk
prepar
tcf
experi
ident
tcf
cell
examin
label
mab
flow
cytometr
analysi
facscan
becton
dickinson
label
red
blood
cell
tcf
lyse
mm
ammonium
chlorid
buffer
ph
remain
cell
incub
pb
nan
pbsnan
min
remov
cytophil
antibodi
watson
indirect
immunofluoresc
carri
incub
either
follow
primari
murin
mab
veterinari
medic
research
develop
inc
pullman
wa
usa
direct
porcin
mhc
class
ii
molecul
respect
well
kindli
provid
bailey
k
haverson
divis
molecular
cellular
immunolog
depart
veterinari
clinic
scienc
univers
bristol
langford
uk
accord
haverson
et
al
direct
antigen
present
neutrophil
monocytesmacrophag
direct
antigen
present
major
neutrophil
eosinophil
recognis
eosinophil
less
blood
neutrophil
antigen
also
found
small
lymphocyt
mab
typespecif
monocytegranulocyt
marker
pescovitz
et
al
secondari
antibodi
fluoresceinconjug
goat
antimous
ig
antibodi
becton
dickinson
san
jose
ca
usa
use
reagent
dilut
pbsnan
incub
carri
min
ice
situ
hybrid
use
crna
probe
porcin
ifna
lefevr
la
bonnadibr
fi
mrna
artursson
et
al
carri
earlier
describ
artursson
et
al
slight
modif
accord
sandberg
et
al
erythrocyt
among
tcf
cell
lyse
describ
whereaft
tcf
cell
fix
paraformaldehyd
merck
darmstadt
germani
pb
transfer
slide
air
dri
store
use
hybrid
perform
high
stringenc
h
probe
formamid
x
ssc
follow
rnase
treatment
slide
cover
nuclear
track
emuls
eastmankodak
rochest
usa
develop
day
ifna
probe
day
ifnp
probe
abil
tcf
cell
respond
prolifer
product
stimul
mitogen
concanavalin
con
pg
ml
pharmacia
determin
cell
cultur
microtit
plate
nunc
roskild
denmark
concentr
x
cell
per
ml
growth
medium
ie
flow
laboratori
mm
hepe
buffer
supplement
lglutamin
mm
penicillin
iu
ml
streptomycin
pug
ml
x
fc
myoclon
gibco
scotland
uk
earlier
describ
porcin
blood
mononuclear
cell
edforslilja
et
al
prolifer
determin
averag
incorpor
radioact
thymidin
kbq
per
well
specif
activ
gbq
mmol
amersham
intern
amersham
uk
express
stimul
index
si
valu
ie
cpm
valu
con
stimul
cultur
divid
cpm
valu
control
cultur
activ
express
percentag
laboratori
standard
porcin
includ
assay
describ
detail
edforslilja
et
al
ifna
produc
capac
tcf
cell
determin
cultur
stimul
fix
cell
prepar
describ
x
cell
per
well
h
c
cultur
supernat
collect
ifncu
content
determin
earlier
mention
delfia
artursson
et
al
ifna
produc
capac
also
determin
method
whole
blood
cultur
wallgren
et
al
heparin
blood
dilut
growth
medium
establish
experiment
anim
capac
tcf
cell
x
cell
ml
hank
balanc
salt
solut
phagocytos
zymosan
particl
sigma
st
loui
mo
usa
opson
normal
spf
pig
serum
assess
luminol
x
aldrich
steinheim
germani
enhanc
chemiluminesc
assay
light
emiss
sampl
measur
everi
minut
min
micropl
luminomet
microlumat
lb
p
eg
g
berthold
bad
wildbad
germani
antibodi
glycoprotein
gb
adv
serum
tcf
detect
competit
elisa
svanovir
eiakit
svanova
biotech
uppsala
sweden
sampl
titrat
twofold
dilut
consid
neg
accord
manufactur
instruct
initi
postop
swell
surround
tissu
implant
chamber
seem
well
toler
anim
oper
wound
heal
rapidli
allow
initi
inflammatori
reaction
declin
tissu
chamber
left
posit
week
first
sampl
collect
first
set
pig
two
eight
second
set
eight
implant
tissu
chamber
becam
infect
infect
eight
chamber
detect
close
surgeri
first
occas
sampl
two
chamber
becam
infect
cours
experi
one
infect
chamber
staphylococcu
hyicu
isol
chamber
streptococcu
equisimili
isol
local
infect
develop
abscess
heal
without
residu
remov
chamber
infect
tissu
chamber
exclud
experi
remov
pig
anatom
locat
tissu
chamber
ie
flank
later
neck
influenc
incid
post
oper
infect
sampl
collect
procedur
cellular
cytokin
respons
tcf
examin
grossli
section
month
post
surgeri
chamber
surround
subcutan
connect
tissu
enclos
tight
capsul
connect
tissu
strand
connect
tissu
grew
capsul
trough
hole
chamber
wall
mass
granul
tissu
insid
end
chamber
strand
clot
fibrin
fill
unperfor
part
tissu
chamber
histolog
tissu
insid
chamber
consist
partial
organ
hematoma
connect
tissu
blood
vessel
moder
infiltr
inflammatori
cell
seen
connect
tissu
mostli
neutrophil
macrophag
occasion
also
polynucl
giant
cell
capsul
surround
tissu
chamber
consist
broad
inner
layer
collagen
rich
connect
tissu
thin
peripher
layer
connect
tissu
numer
blood
vessel
moder
infiltr
mononuclear
cell
region
lymph
node
gener
reactiv
case
slight
hypertrophi
occasion
activ
lymphoid
follicl
note
volum
tcf
obtain
sampl
vari
ml
ml
regardless
size
chamber
sampl
volum
tcf
could
still
recov
seven
month
implant
repeat
sampl
collect
often
four
time
h
decreas
acquir
volum
tcf
amount
red
blood
cell
fluid
increas
procedur
number
nucleat
cell
tcf
obtain
untreat
chamber
mean
x
ml
f
sd
n
histolog
cell
determin
mostli
polymorphonuclear
leukocyt
neutrophil
granulocyt
eosinophil
granulocyt
identifi
monocyt
lymphocyt
character
cell
tcf
carri
mean
immunofluoresc
label
flow
cytometr
analysi
cell
gate
exclud
contamin
erythrocyt
cell
debri
subsequ
divid
mononuclear
polymorphonuclear
cell
popul
basi
forward
right
angl
light
scatter
among
mononuclear
cell
tcf
untreat
chamber
n
n
f
mhc
class
ii
n
monocytegranulocyt
marker
mab
use
gate
mononuclear
cell
gate
granulocyt
tcf
untreat
chamber
posit
label
n
correspond
percentag
monocyt
identifi
histolog
among
mononuclear
cell
tissu
chamber
sampl
fluid
collect
five
chamber
inject
poli
c
contain
low
level
ifno
h
fig
level
ifna
peak
h
still
elev
h
post
inject
tnf
respons
prompt
observ
eno
reach
peak
valu
h
post
inject
tnf
level
remain
elev
h
poli
c
inject
return
basal
level
h
eni
detect
tcf
serum
inject
poli
c
cytokin
respons
remain
local
ie
ifncr
tnf
detect
control
chamber
poli
c
treat
pig
trace
amount
ifnn
unit
h
detect
serum
one
poli
c
inject
pig
tnf
activ
could
detect
serum
anim
studi
influenc
frequent
sampl
collect
pattern
cytokin
respons
result
compar
obtain
experi
fewer
sampl
collect
ie
h
level
ifna
h
concentr
ifna
h
gener
highest
chamber
less
frequent
sampl
collect
one
pig
display
higher
level
ifna
h
experi
sampl
collect
similarli
h
tnf
activ
fig
higher
fluid
three
four
chamber
sampl
collect
less
frequent
fix
adv
infect
cell
porcin
kidney
cell
line
use
noninfect
nonsolubl
rna
induc
ifna
detect
tcf
four
five
chamber
primari
inject
tabl
kinet
level
ifncx
produc
vari
pig
howev
note
right
flank
chamber
pig
high
ifna
level
detect
found
infect
staph
hyicu
experi
case
h
tabl
ifn
level
u
ml
antibodi
titer
adv
tcf
serum
record
indic
time
point
inject
advpki
tissu
chamber
pig
infect
chamber
use
experi
cellular
data
chamber
omit
second
inject
administ
one
week
first
ifn
u
detect
tcf
inject
chamber
contrast
ifn
r
detect
three
chamber
inject
advpki
week
first
inject
blood
mononuclear
cell
experiment
pig
test
vitro
ifnci
product
respons
two
occas
anim
expos
vivo
pig
no
found
produc
higher
level
u
ml
respect
ifncu
vitro
pig
no
u
ifno
respect
thu
pig
produc
lowest
level
ifnr
vivo
also
produc
lowest
level
ifn
vitro
cf
tabl
ipni
detect
serum
tcf
collect
first
two
week
inject
three
week
primari
inject
viru
infect
cell
ifni
detect
inject
chamber
one
pig
right
flank
ng
ml
slaughter
ie
approxim
month
primari
inject
experiment
pig
display
ifni
serum
well
tissu
chamber
right
flank
ng
left
flank
ng
serum
ng
ifni
ml
right
neck
ng
right
flank
ng
left
flank
ng
serum
ng
ifni
ml
tnf
activ
low
undetect
tcf
inject
chamber
inject
alon
induc
product
ifna
ifni
tnf
pig
seroneg
adv
first
inject
viru
infect
cell
none
pig
gain
detect
level
antibodi
adv
serum
tcf
one
week
first
inject
tabl
howev
second
inject
administ
week
first
inject
pig
antibodi
adv
serum
titer
tcf
titer
pig
inject
seroconvert
least
week
primari
inject
slaughter
pig
no
approxim
month
primari
inject
higher
antibodi
titer
adv
detect
serum
tcf
compar
record
time
second
inject
alter
tcf
cell
number
studi
inject
poli
c
cell
compar
chamber
inject
nacl
subject
sampl
collect
fig
signific
n
alter
total
tcf
cell
number
found
repeat
sampl
collect
chamber
inject
nacl
howev
total
number
nucleat
cell
tend
increas
sampl
collect
p
h
vs
h
n
significantli
differ
correspond
valu
nontreat
chamber
poli
c
inject
pronounc
increas
total
number
nucleat
cell
tcf
obtain
h
p
h
vs
h
note
treat
chamber
cell
number
also
significantli
higher
untreat
chamber
p
h
p
h
well
chamber
inject
nacl
p
h
p
h
time
point
proport
neutrophil
granulocyt
increas
sampl
collect
untreat
tissu
chamber
f
f
k
f
neutrophil
h
respect
mean
valu
f
sd
n
chamber
inject
nacl
f
f
neutrophil
h
respect
mean
valu
k
sd
p
h
vs
h
n
chamber
inject
poli
c
neutrophil
h
respect
mean
valu
sd
p
h
vs
h
n
inject
shown
figur
induc
chang
total
number
composit
cell
tcf
observ
untreat
nacl
inject
tissu
chamber
test
one
week
chamber
inject
poli
c
cell
total
number
cell
proport
differ
cell
popul
f
x
nucleat
cell
ml
tcf
neutrophil
granulocyt
eosinophil
granulocyt
f
monocyt
lymphocyt
mean
valu
f
sd
n
significantli
differ
record
treatment
administr
solubl
poli
c
nonsolubl
ifna
induc
chamber
result
local
cytokin
product
case
poli
c
accompani
influx
nucleat
cell
attempt
identifi
cell
indirect
label
mab
direct
differ
surfac
antigen
porcin
myeloid
cell
carri
tcf
cell
experi
fig
although
limit
number
observ
made
result
indic
proport
granulocyt
decreas
p
h
vs
h
n
proport
granulocyt
tend
ns
increas
tcf
sampl
collect
regardless
treatment
proport
granulocyt
express
respect
show
small
variat
chamber
time
point
reflect
low
sd
valu
among
mononuclear
tcf
cell
proport
posit
cell
remain
constant
experi
data
shown
proport
mononuclear
cell
howev
approxim
doubl
poli
c
inject
f
h
respect
mean
valu
sd
n
compar
treatment
h
respect
mean
valu
sd
n
addit
rnarna
situ
hybrid
probe
specif
porcin
en
ifnp
appli
sampl
cell
recov
tcf
collect
pig
no
inject
cell
although
major
sampl
neg
occasion
cell
approxim
per
x
heavili
label
either
ifna
mrna
detect
sampl
collect
h
inject
viabil
function
capac
cell
recov
tcf
analyz
vitro
function
test
ie
con
induc
prolifer
product
vitro
ifna
induct
luminolenhanc
chemiluminesc
assay
mitogen
induc
prolifer
tcf
cell
express
si
valu
rang
si
f
mean
valu
sd
n
activ
supernat
cultur
rang
mean
valu
sd
n
ifn
product
tcf
cell
vitro
show
larg
variat
rang
unit
ifna
u
ml
mean
valu
sd
n
granulocyt
recov
tcf
exhibit
phagocyt
activ
determin
light
emiss
chemiluminesc
assay
rfr
cp
mean
peak
valu
sd
ii
thu
viabl
cell
could
recov
tcf
use
vitro
experi
tissu
chamber
model
vivo
studi
local
inflammatori
respons
cytokin
product
cell
recruit
establish
pig
tissu
chamber
well
toler
anim
pig
could
hous
normal
condit
sampl
collect
easili
perform
affect
grow
pig
kg
enabl
use
experiment
anim
long
period
time
moreov
content
cytokin
tcf
could
monitor
short
interv
sinc
amount
fluid
recov
chamber
remain
constant
even
collect
frequent
main
problem
observ
studi
occurr
postop
infect
chamber
total
implant
chamber
becam
infect
bacteria
commonli
present
skin
pig
howev
two
chamber
becam
infect
experi
indic
infect
seldom
introduc
sampl
collect
instead
like
close
proxim
chamber
skin
wound
augment
risk
infect
especi
second
set
pig
four
chamber
implant
thu
rest
wound
heal
implant
tissu
chamber
one
side
pig
post
surgic
infect
wound
appear
less
frequent
accord
first
second
set
present
studi
possibl
anim
could
rest
non
oper
side
similar
model
use
larger
anim
ie
cattl
bengtsson
et
al
frequenc
infect
tissu
chamber
initi
figur
reduc
almost
nil
extend
distanc
tissu
chamber
skin
wound
bengtsson
person
commun
introduc
antibiot
treatment
anim
preand
postop
period
bengtsson
consequ
precaut
could
taken
reduc
risk
postop
infect
also
porcin
model
instanc
might
benefici
use
largerold
pig
oper
cytokin
respons
studi
tcf
administr
fix
advinfect
cell
poli
c
known
induc
product
type
ifn
addit
poli
c
induc
product
sever
cytokin
tnf
bun
et
al
north
et
al
pyo
et
al
present
experi
kinet
ifna
tnf
could
monitor
simultan
tissu
chamber
inject
poli
c
highest
level
tnf
achiev
first
sampl
gradual
decreas
en
level
increas
first
three
occas
sampl
thu
sampl
collect
procedur
margin
affect
kinet
magnitud
cytokin
respons
poli
c
induc
ifna
product
tcf
howev
delay
compar
earlier
record
system
administr
induc
highest
ifn
level
record
alreadi
h
intraven
inject
poli
c
pig
vengri
mare
loewen
derbyshir
discrep
probabl
due
rapid
degrad
induc
administ
system
fact
rapid
hydrolysi
poli
c
serum
ribonucleas
observ
human
nordlund
et
al
advantag
tissu
chamber
model
could
therefor
metabol
substanc
instanc
liver
could
avoid
delay
kinet
ifnrr
respons
induc
inject
tissu
chamber
resembl
induc
poli
c
magnitud
respons
vari
individu
individu
variat
ifn
w
product
similarli
observ
intraderm
administr
pig
artursson
et
al
well
document
ifna
product
porcin
leukocyt
induc
vitro
edforslilja
et
al
inde
leukocyt
obtain
pig
produc
detect
amount
ifna
tcf
primari
inject
respond
poorli
ifnlu
induct
vitro
second
inject
administ
tissu
chamber
week
primari
inject
ifncx
respons
abolish
inhibit
ifna
respons
like
due
presenc
antibodi
adv
tcf
time
sinc
antibodi
certain
viral
glycoprotein
inhibit
ifna
product
vitro
lebon
charley
laud
ankel
et
al
contrast
markedli
higher
ifn
level
notic
induct
bacteri
infect
tissu
chamber
magnitud
ifna
respons
increas
vitro
addit
cytokin
cell
cultur
cederblad
aim
charley
et
al
wattrang
et
al
enhanc
ifn
product
observ
bacteri
infect
man
ikossioconnor
chadha
thu
prime
effect
ifna
produc
cell
inflammatori
cytokin
could
explain
high
ifna
level
infect
tissu
chamber
ifni
detect
sampl
collect
first
h
inject
induc
howev
ifni
record
tcf
week
inject
one
pig
serum
tcf
experiment
pig
month
inject
system
longlast
ifni
respons
suggest
ongo
immun
respons
possibl
trigger
local
preserv
antigen
contrast
ifn
tnf
respons
induc
experi
stay
local
tissu
chamber
question
allow
anim
control
short
term
experi
besid
cytokin
respons
number
composit
nucleat
cell
tcf
studi
frequent
sampl
collect
total
number
tcf
cell
remain
rather
constant
although
proport
neutrophil
granulocyt
increas
immunofluoresc
label
confirm
shift
tcf
cell
composit
determin
histolog
character
tcf
cell
instanc
proport
granulocyt
express
antigen
among
granulocyt
present
neutrophil
haverson
et
al
increas
moreov
proport
granulocyt
express
antigen
present
major
eosinophil
neutrophil
haverson
et
al
decreas
sampl
collect
promin
chang
tcf
cell
number
howev
rapid
increas
neutrophil
number
proport
increas
mononuclear
cell
observ
inject
poli
c
alter
probabl
mediat
local
produc
cytokin
instanc
tnf
increas
express
adhes
molecul
endotheli
cell
well
leukocyt
thu
contribut
accumul
neutrophil
granulocyt
vassal
although
limit
number
observ
cell
identif
undertaken
result
clearli
indic
present
tissu
chamber
model
could
use
studi
cell
recruit
addit
cell
recov
tcf
viabl
could
use
sever
function
assay
taken
togeth
tissu
chamber
model
offer
novel
opportun
studi
exampl
immun
inflammatori
respons
natur
context
ie
presenc
cytokin
accessori
cell
popul
vitro
find
verifi
experiment
modul
vivo
condit
local
system
treatment
deplet
cell
popul
administr
antibodi
pharmaceut
